• Vancouver Tech Journal
  • Posts
  • Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment

Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment

Plus, it generated a net profit of $119 million USD, up from a net loss of $2 million on $11.6 million in revenue.

Author

William Johnson
March 29, 2021

Premium Content

Become a paying subscriber of Vancouver Tech Journal to get access to this page and other subscriber-only content.

What you get when you upgrade:
  • 🔑 Exclusive content: In-depth stories that you won't find anywhere else
  • 🎟️ First access to events we put on
  • 🔒 The Morning Report, an email digest of need-to-know stories and deals
  • 🗓️ Discounted and invitation-only events
Already a subscriber?Sign In.Upgrade to view premium content.